Keywords: مهار کننده های آنژیوژنز; Jaw diseases; Osteonecrosis; Bisphosphonate-associated osteonecrosis of the jaw; Bone; Bone density conservation agents; Angiogenesis inhibitors;
مقالات ISI مهار کننده های آنژیوژنز (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: مهار کننده های آنژیوژنز; Dovitinib; Vascular endothelial growth factors; Fibroblast growth factors; Angiogenesis inhibitors;
Keywords: مهار کننده های آنژیوژنز; Antineoplastic agents/adverse effects; Angiogenesis inhibitors; Cardiotoxins; Vascular endothelial growth factor; Bevacizumab; Sorafenib; Sunitinib; Vandetanib; Aflibercept;
Keywords: مهار کننده های آنژیوژنز; Lenalidomide derivatives; Angiogenesis inhibitors; Molecular docking; Synthesis; CCK-8;
Keywords: مهار کننده های آنژیوژنز; Colorectal cancer; Second-line chemotherapy; Angiogenesis inhibitors; Systematic review; Pooled analysis;
Keywords: مهار کننده های آنژیوژنز; Angiogenesis inhibitors; Receptor protein-tyrosine kinase; Tumor microenvironment; Natural products;
Keywords: مهار کننده های آنژیوژنز; Ovarian cancer; Genomics; Molecular subtype; Target therapy; Angiogenesis inhibitors; PARP inhibitors; Anti-folate receptor treatment; Anti-cancer stem cells treatment;
Keywords: مهار کننده های آنژیوژنز; Angiogenesis inhibitors; Neovascularization; Pharmacokinetics; Pharmacodynamics; Protein kinase inhibitors; Monoclonal antibodies;
Keywords: مهار کننده های آنژیوژنز; Angiogenesis inhibitors; Vascular normalization; Vascular promotion; Cancer therapy;
Keywords: مهار کننده های آنژیوژنز; Vascular endothelial growth factor A; Cancer; Angiogenesis inhibitors; Toxicity; Stroke; Posterior reversible encephalopathy syndrome; Hypertension; Cardiovascular risk factors; Cerebral radiotherapy;
Keywords: مهار کننده های آنژیوژنز; Angiogenesis inhibitors; Hypertension; Overall survival; Predictive biomarker; Progression-free survival; Renal cell carcinoma;
Keywords: مهار کننده های آنژیوژنز; Gastric neoplasms; Angiogenesis inhibitors; Antineoplastic agents; Vascular endothelial growth factor antagonists and inhibitors; Controlled clinical trial; Antineoplastic combined chemotherapy protocols;
Keywords: مهار کننده های آنژیوژنز; Renal cell carcinoma; Elderly; Nephrectomy; Angiogenesis inhibitors; Mammalian target of rapamycin inhibitors; Programmed death 1; Immunotherapy;
Keywords: مهار کننده های آنژیوژنز; ECM; extracellular matrix; IFP; interstitial fluid pressure; EPR; enhanced permeation and retention; AI; angiogenesis inhibitors; VEGF; vascular endothelial growth factor; VDA; vascular disrupting agent; CEP; circulating endothelial progenitor; TACE; tran
Keywords: مهار کننده های آنژیوژنز; Arterial thromboembolic events; VEGFR–TKIs; Angiogenesis inhibitors; Meta-analysis
Keywords: مهار کننده های آنژیوژنز; Acute coronary syndromes; Angiogenesis inhibitors; IGF-1; Growth factors; VEGF;
Predictors of Long-Term Response With Pazopanib in Patients With Advanced Renal-Cell Carcinoma
Keywords: مهار کننده های آنژیوژنز; Angiogenesis inhibitors; Kidney cancer; RCC; Tyrosine kinase inhibitor; Vascular endothelial growth factor;
Surveillance de l'hypertension artérielle chez les patients traités par anti-angiogénique par voie orale en pratique quotidienne
Keywords: مهار کننده های آنژیوژنز; Effets indésirables; Hypertension artérielle; Inhibiteurs de l'angiogenèse; Inhibiteur de la tyrosine kinase; Insuffisance rénale; Protéinurie; Thérapie moléculaire ciblée; Adverse effects; Angiogenesis inhibitors; Hypertension; Molecular target
A Vascular Endothelial Growth Factor-Dependent Sprouting Angiogenesis Assay Based on an In Vitro Human Blood Vessel Model for the Study of Anti-Angiogenic Drugs
Keywords: مهار کننده های آنژیوژنز; Angiogenesis inhibitors; DLL4; Human umbilical vein endothelial cell; In vitro 3D model; Microvessel; Notch; Sorafenib; Sprouting angiogenesis; Sunitinib; Vascular endothelial growth factor; 3D; three-dimensional; BSA; bovine serum albumin; CLSM; confocal
Vascular toxicities with VEGF inhibitor therapies-focus on hypertension and arterial thrombotic events
Keywords: مهار کننده های آنژیوژنز; Angiogenesis inhibitors; cardiovascular events; chemotherapy; hypertension;
Efficacy of Ciji Hua'ai Baosheng formula on the expressions of vascular endothelial growth factor, kinase insert domain-containing receptor and basic fibroblast growth factor in mouse models of H22 hepatocellular carcinoma
Keywords: مهار کننده های آنژیوژنز; Drug therapy; Angiogenesis inhibitors; Vascular endothelial growth factors; Receptors, vascular endothelial growth factor; Basic fibroblast growth factor 2; Ciji Hua'ai Baosheng formula;
Antiangiogenic Therapy in Advanced Non-small-cell Lung Cancer: A Meta-analysis of Phase III Randomized Trials
Keywords: مهار کننده های آنژیوژنز; Angiogenesis inhibitors; Lung neoplasm; Response rate; Survival; Systematic review;
Design, synthesis and biological evaluation of novel alkyl diamine linked bivalent β-carbolines as angiogenesis inhibitors
Keywords: مهار کننده های آنژیوژنز; Synthesis; Bivalent β-carbolines; Antitumor; Angiogenesis inhibitors; Structure-activity relationships;
Evaluation of antitumor and anti-angiogenic activity of bioactive compounds from Cinnamomum tamala: In vitro, in vivo and in silico approach
Keywords: مهار کننده های آنژیوژنز; Cinnamomum tamala; Antitumor drug screening assays; Antitumor agents; Angiogenesis inhibitors; Molecular docking analysis
First-line antiangiogenics for metastatic renal cell carcinoma: A systematic review and network meta-analysis
Keywords: مهار کننده های آنژیوژنز; Renal cell carcinoma; Angiogenesis inhibitors; Meta-analysis
Zebrafish (Danio rerio) embryo as a platform for the identification of novel angiogenesis inhibitors of retinal vascular diseases
Keywords: مهار کننده های آنژیوژنز; Angiogenesis; Angiogenesis inhibitors; Embryonic development; Vascular retina diseases; Zebrafish;
Synthesis and biological evaluation of novel alkyl diamine linked bivalent β-carbolines as angiogenesis inhibitors
Keywords: مهار کننده های آنژیوژنز; Synthesis; Bivalent β-carbolines; Antitumor; Angiogenesis inhibitors; Structure-activity relationships;
A Phase II Study of GW786034 (Pazopanib) With or Without Bicalutamide in Patients With Castration-Resistant Prostate Cancer
Keywords: مهار کننده های آنژیوژنز; Angiogenesis inhibitors; CRPC; Patient selection; PSA response;
Anti-angiogenic-specific adverse events in patients with non-small cell lung cancer treated with nintedanib and docetaxel
Keywords: مهار کننده های آنژیوژنز; Non-small cell lung cancer; Angiogenesis inhibitors; Drug-related side effects and adverse reactions;
Correlation of Lactate Dehydrogenase Isoenzyme Profile With Outcome in Patients With Advanced Colorectal Cancer Treated With Chemotherapy and Bevacizumab or Cediranib: Retrospective Analysis of the HORIZON I Study
Keywords: مهار کننده های آنژیوژنز; Angiogenesis inhibitors; FOLFOX regimen; Hypoxia; LDH; Predictive biomarkers
A phase 1b, open-label study of trebananib in combination with paclitaxel and carboplatin in patients with ovarian cancer receiving interval or primary debulking surgery
Keywords: مهار کننده های آنژیوژنز; Angiogenesis inhibitors; Angiopoietin-1; Angiopoietin-2; Tie2 receptor; Combination drug therapy;
Antiangiogenesis beyond VEGF inhibition: A journey from antiangiogenic single-target to broad-spectrum agents
Keywords: مهار کننده های آنژیوژنز; Angiogenesis inhibitors; Bevacizumab; Drug therapy; Endostatin; Monoclonal antibodies; Protein-tyrosine kinases; Sunitinib; Vascular endothelial growth factor
Endothelial dysfunction and hypertension in obstructive sleep apnea - Is it due to intermittent hypoxia?
Keywords: مهار کننده های آنژیوژنز; Angiogenesis inhibitors; Sleep apnea; Hypertension; Endothelial dysfunction;
Mounting a strategic offense: fighting tumor vasculature with oncolytic viruses
Keywords: مهار کننده های آنژیوژنز; oncolytic virotherapy; oncolytic virus; tumor vasculature; antivascular therapy; angiogenesis inhibitors; vascular disruption
Antiangiogenic agents as a maintenance strategy for advanced epithelial ovarian cancer
Keywords: مهار کننده های آنژیوژنز; Angiogenesis inhibitors; Epithelial ovarian cancer; Vascular endothelial growth factor; Molecular targeted therapy; Bevacizumab
Intracameral bevacizumab (Avastin®) in the management of neovascular glaucoma surgery
Keywords: مهار کننده های آنژیوژنز; Bevacizumab; Glaucoma neovascular; Filtering surgery; Angiogenesis inhibitors; Injections intraocularBevacizumab; Glaucoma neovascular; Cirugía filtrante; Antiangiogénicos; Inyección intraocular
Bevacizumab (Avastin®) intracamerular en el manejo quirúrgico del glaucoma neovascular
Keywords: مهار کننده های آنژیوژنز; Bevacizumab; Glaucoma neovascular; Cirugía filtrante; Antiangiogénicos; Inyección intraocularBevacizumab; Glaucoma neovascular; Filtering surgery; Angiogenesis inhibitors; Injections intraocular
Pemetrexed, oxaliplatin and bevacizumab as first-line treatment in patients with stage IV non-small cell lung cancer
Keywords: مهار کننده های آنژیوژنز; Non-small cell lung cancer; Pemetrexed; Oxaliplatin; Bevacizumab; VEGF-A; Angiogenesis inhibitors
Combination or sequencing strategies to improve the outcome of metastatic renal cell carcinoma patients: A critical review
Keywords: مهار کننده های آنژیوژنز; Angiogenesis inhibitors; Combination; Cytokines; Renal cell carcinoma; Sequencing
Controlling angiogenesis in breast cancer: A systematic review of anti-angiogenic trials
Keywords: مهار کننده های آنژیوژنز; Breast neoplasms; Angiogenesis inhibitors; Antineoplastic agents; Vascular endothelial growth factor antagonists and inhibitors; Controlled clinical trial as topic; Antineoplastic combined chemotherapy protocols
Targeted therapies for advanced non-small-cell lung cancer: Current status and future implications
Keywords: مهار کننده های آنژیوژنز; Advanced non-small-cell lung cancer; Combining targeted therapies; Epidermal growth factor receptor inhibitors; Angiogenesis inhibitors; Multitargeted tyrosine quinase inhibitors
An overview of clinical and experimental treatment modalities for port wine stains
Keywords: مهار کننده های آنژیوژنز; angiogenesis inhibitors; epidermal cooling; hypobaric pressure; immunomodulators; photodynamic therapy; pulsed dye laser; site-specific pharmaco-laser therapy; superficial vascular and capillary malformations; FDA; Food and Drug Administration; IPL; inten
Predictors of response to sequential sunitinib and the impact of prior VEGF-targeted drug washout in patients with metastatic clear-cell renal cell carcinoma
Keywords: مهار کننده های آنژیوژنز; Sunitinib; Sorafenib; Bevacizumab; Angiogenesis inhibitors; Sequential therapy
Phase 2 trial of linifanib (ABT-869) in patients with advanced renal cell cancer after sunitinib failure
Keywords: مهار کننده های آنژیوژنز; Renal cell carcinoma; Sunitinib; ABT-869; VEGFR; Angiogenesis inhibitors;
An integrin-binding N-terminal peptide region of TIMP-2 retains potent angio-inhibitory and anti-tumorigenic activity in vivo
Keywords: مهار کننده های آنژیوژنز; Angiogenesis; Angiogenesis inhibitors; Tissue inhibitor of metalloproteinases-2 (TIMP-2); Peptide inhibitors; Kaposi's sarcoma;
Phase II Study of Neoadjuvant Bevacizumab and Radiotherapy for Resectable Soft Tissue Sarcomas
Keywords: مهار کننده های آنژیوژنز; Sarcoma; Angiogenesis inhibitors; Radiotherapy; Bevacizumab; Biomarkers;
Trans-arterial chemoembolization as a therapy for liver tumours: New clinical developments and suggestions for combination with angiogenesis inhibitors
Keywords: مهار کننده های آنژیوژنز; Trans-arterial chemoembolization (TACE); Liver tumours; DC-Beads; HepaSphere; Doxorubicin; Irinotecan; VEGF; Angiogenesis; Angiogenesis inhibitors
An angiogenesis inhibitor isolated from a marine-derived actinomycete, Nocardiopsis sp. 03N67
Keywords: مهار کننده های آنژیوژنز; Marine actinomycetes; Angiogenesis inhibitors; HUVECs; Diketopiperazine; Cyclo-(l-Pro-l-Met);
Novel Treatment Approaches for Triple-Negative Breast Cancer
Keywords: مهار کننده های آنژیوژنز; Angiogenesis inhibitors; BRCA; DNA repair; PARP inhibitors
Targeted therapeutic approaches for hormone-refractory prostate cancer
Keywords: مهار کننده های آنژیوژنز; Hormone-refractory prostate cancer; Targeted therapy; Vitamin D analogues; Angiogenesis inhibitors; Endothelin receptor antagonists; Apoptotic pathways; Molecular chaperone; Tyrosine kinase inhibitors; Immunotherapy